Skip to main content
. 2016 Apr 28;11(4):e0153757. doi: 10.1371/journal.pone.0153757

Table 1. Details of the clinical diagnoses and genetic pathology identified in individuals in this study.

Individual ID DECIPHER ID Clinical feature Genetic pathology Genomic coordinates (hg18)
1851 (control) 323119 Aniridia PAX6 deletion (previously identified by FISH) chr11:21,254,000–32,564,000
2193 323118 Aniridia PAX6 whole-gene deletion chr11:31,199,000–31,849,000
377 323104 Aniridia PAX6 whole-gene deletion chr11:31,394,000–31,914,000
1510 323113 Aniridia PAX6 whole-gene deletion chr11:31,779,000–31,933,000)
1977 323116 Aniridia PAX6 whole-gene deletion chr11:31,698,271–31,794,414
1514 323114 Aniridia PAX6 telomeric deletion chr11:30,874,642–31,654,833
753 323108 Aniridia PAX6 telomeric deletion chr11:30,967,000–31,704,000)
555 323106 Aniridia PAX6 telomeric deletion chr11:31,108,579–31,649,842)
2014 323117 Gillespie syndrome PAX6 telomeric deletion chr11:31,234,395–31,751,815
659 323107 Aniridia PAX6 telomeric deletion chr11:31,379,000–31,708,000)
1449 323112 Gillespie syndrome FOXC1 whole-gene deletion chr6:1,543,591–1,675,085
1246 323110 Aniridia FOXC1 whole-gene deletion chr6:1,543,591–1,675,085
1839 Aniridia FOXC1 c.235C>A p.(Pro79Thr) de novo Not applicable
1634 Aniridia FOXC1 c.302T>C p.(Leu101Pro) de novo Not applicable
1194 323109 Aniridia PITX2 telomeric deletion chr4:111,994,000–115,504,000
1371 n/a Gillespie syndrome Translocation t(X;11)(p22.32;p12) See Fig 5